Results 11 to 20 of about 7,370,283 (214)

Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy [PDF]

open access: yes, 2021
Purpose Pathologic complete response is associated with longer disease-free survival and better overall survival after neoadjuvant chemotherapy in breast cancer patients.
Solomayer, Erich-Franz   +6 more
core   +1 more source

Complete pathologic response as a prognostic factor for squamous cell carcinoma of the oropharynx post-chemoradiotherapy [PDF]

open access: yes, 2015
IntroductionChemoradiotherapy for squamous cell carcinoma of the oropharynx (SCCO) provides good results for locoregional disease control, with high rates of complete clinical and pathologic responses, mainly in the neck.ObjectiveTo determine whether ...
Auro Del Giglio   +20 more
core   +2 more sources

A pathological complete response after neoadjuvant triplet chemotherapy for locally advanced transverse colon cancer [PDF]

open access: yes, 2020
Introduction: Perioperative chemotherapy could improve oncological outcomes for patients with advanced colon cancer. However, the effectiveness of triplet chemotherapy in the neoadjuvant setting is still unknown.
Tominaga, Tetsuro   +4 more
core   +1 more source

Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast [PDF]

open access: yes, 2008
Introduction To investigate the predictive value of clinical and biological markers for a pathological complete remission after a preoperative dose-dense regimen of doxorubicin and docetaxel, with or without tamoxifen, in primary operable breast cancer ...
Sinn, Hans-Peter   +27 more
core   +2 more sources

A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial [PDF]

open access: yes, 2013
Background: Neo-tAnGo, a National Cancer Research Network (NCRN) multicentre randomised neoadjuvant chemotherapy trial in early breast cancer, enroled 831 patients in the United Kingdom.
K Walland   +25 more
core   +2 more sources

Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer [PDF]

open access: yes, 2020
Objective: This study was conducted in order to determine the optimal timing of diffusion-weighted magnetic resonance imaging (DW-MRI) for prediction of pathologic complete response (pCR) to neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer ...
Lagendijk, Jan J W   +11 more
core   +1 more source

Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy [PDF]

open access: yes, 2005
To prospectively compare the ability of clinical examination, mammography, vascularity-sensitive ultrasound, and magnetic resonance imaging (MRI) to determine pathologic complete response (CR) in breast cancer patients undergoing neoadjuvant chemotherapy.
Hayes, Daniel F.   +11 more
core   +1 more source

Association between pathologic response and survival after neoadjuvant therapy in lung cancer. [PDF]

open access: yes, 2023
Neoadjuvant immunotherapy plus chemotherapy improves event-free survival (EFS) and pathologic complete response (0% residual viable tumor (RVT) in primary tumor (PT) and lymph nodes (LNs)), and is approved for treatment of resectable lung cancer ...
Forde, Patrick M   +23 more
core   +1 more source

Predictors of pathologic complete response following NAC.

open access: yes, 2019
Predictors of pathologic complete response following NAC.
Nusayba A. Bagegni (7406345)   +2 more
core   +1 more source

Correlation of utDNA MRD detection and pathologic response with OS.

open access: yes, 2021
OS analysis according to utDNA MRD detection at the preoperative time point (A) and pathologic response assessed in the radical cystectomy specimen (B). HRs and p-values were calculated using the Mantel–Haenszel and Mantel–Cox methods, respectively.
Jeffrey J. Szymanski (11361789)   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy